EJCTS Click here to go to Edwards website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Marcus P. Haw
James L. Monro
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dalrymple-Hay, M. J.R.
Right arrow Articles by Monro, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dalrymple-Hay, M. J.R.
Right arrow Articles by Monro, J. L.

Eur J Cardiothorac Surg 1999;15:830-834
© 1999 Elsevier Science NL


Autotransfusion of washed shed mediastinal fluid decreases the requirement for autologous blood transfusion following cardiac surgery: a prospective randomized trial

Malcolm J.R. Dalrymple-Hay, Louise Pack, Charles D. Deakin, Stuart Shephard, Sunil K. Ohri, Marcus P. Haw, Steven A. Livesey, James L. Monro

Wessex Cardiothoracic Centre, Department of Cardiothoracic Surgery, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK

Received 14 December 1998; received in revised form 26 February 1999; accepted 11 March 1999.

Corresponding author. Tel.: +44-1703-796-124; fax: +44-1703-796-614
e-mail: mdh{at}btinternet.com


    Abstract
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 References
 
Objectives: The National Blood Service issues 2.2 million units of blood per year, 10% of these (220 000) are utilized in cardiac procedures. Transfusion reactions, infection risk and cost should stimulate us to decrease this transfusion rate. We test the efficacy of autotransfusion following surgery in a prospective randomized trial. Methods: One hundred and twelve patients undergoing CABG, valve or CABG+valve procedures were randomized into two groups. Group A received washed postoperative drainage fluid and group C were controls. The indication for transfusion was a postoperative haemoglobin (Hb) <10 g/l or a PCV<30. There was no significant difference in preoperative and operative variables between the groups. Results: Twenty-eight patients in group A and 46 in group C required homologous transfusion (P=0.0008). Group A patients required 298±49 ml of banked blood per patient, group C 508±49 ml (P=0.003). There was no difference in total blood required (volume autotransfused+volume banked blood transfused) between the groups (group A 404±50 ml, group C 508±50 ml) or in mean total mediastinal fluid drainage (group A 652±51 ml, group C 686±50ml). The mean Hb concentration was significantly higher in group A on day 1 (11.2 g/dl±51 vs.10.6 g/dl±13 (P=0.002)). No morbidity was associated with autotransfusion. Conclusion: Autotransfusion can decrease the amount of homologous blood transfused following cardiac surgery. This represents a benefit to the patient and a decrease in cost to the health service.

Key Words: Autotransfusion • Blood transfusion • Mediastinal drainage fluid


    1. Introduction
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 References
 
The National Blood Service in the UK issues approximately 2.2 million units of blood per year [1] and about 10% of these are utilized in cardiac procedures [2]. Despite ever-improving blood conservation techniques, 75% of patients undergoing coronary artery bypass graft operations (CABG) receive at least one transfusion [3]. There are a number of adverse effects associated with the use of banked blood, the most clinically relevant being transfusion reactions and infection [4].

Screening tests are employed to ensure that the risk of transmitting human immunodeficiency virus (HIV), human T cell lymphotrophic virus (HTLV), hepatitis-C virus (HCV), hepatitis-B virus (HBV) is small and Schreiber et al. estimated an aggregate risk for these diseases of one in 34 000. Infection with unidentifiable or unknown infectious agents following transfusion still, however, represents a risk [5]. Recently, the possibility of transmitting spongiform encephalopathies, a notably new variant CJD (Creutzfeldt–Jacob Disease), via blood transfusions has been recognized. Despite the World Health Organization concluding that there is no proved transmission of CJD by blood, lack of evidence of risk is not evidence of absence of risk [6,7].

The use of homologous transfusion has also been associated with an increased risk of bacterial infection following CABG and a decrease in immune function, which may increase the severity of an infection [4]. These immunosuppressive changes include an increase in numbers of suppressor T-lymphocytes, a decrease in numbers of helper T-lymphocytes, a decrease in natural killer cell function, a decrease in the function of macrophages and monocytes, reduced responses in mixed lymphocyte culture and decreases in cytokine production [8].

While blood donors in Britain are unpaid, the collection, processing, testing, inventory and administration of each unit of blood adds incrementally to its ultimate cost [9], with the price of one unit of packed red cells currently being at least £40 [2].

Attempts to minimize transfusion and avoid as many of these associated risks and costs as possible are therefore sensible. We test the efficacy of autotransfusion of washed postoperative mediastinal fluid in a prospective randomized trial.


    2. Methods
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 References
 
Ethics committee approval was granted and informed written consent obtained from all patients. One hundred and twelve adult patients undergoing either coronary artery bypass grafting, valve replacement/repair operations or a combination of the two were randomized preoperatively into two groups using a binary random number table. Exclusion criteria for the study were; previous cardiac surgery, emergency operations, patients anticoagulated with warfarin and Jehovah Witness patients.

Surgery was performed using membrane oxygenators and the preferred myocardial preservation technique of the individual surgeons. If the Hb fell to less than 7 g/dl or PCV to less than 0.2 during cardiopulmonary bypass, banked blood was transfused in both groups.

At the end of surgery, mediastinal and, if applicable, pleural drains were connected to a blood collection reservoir.

Postoperatively, patients returned to Cardiothoracic ITU where drainage loss was recorded half hourly for 4 h and then hourly. Hb and PCV measurements were performed on all patients on arrival in the unit and then at 2-h intervals, or as clinically indicated. The indication for transfusion was a Hb less than 10 g/dl or PCV less than 0.3. At these Hb and PCV thresholds, banked blood was transfused in group C patients and washed mediastinal fluid in group A. In such circumstances for group A patients, the autotransfusion program was operated (Fresenius C.A.T.S.® – continuous autotransfusion system) and the washed drainage fluid transfused.

The mediastinal drainage fluid undergoes a washing process which comprises three successive stages and takes place in a centrifuge disc. The initial separation stage concentrates the fluid of blood to a haematocrit of approximately 0.8 and the removal of blood plasma, cellular debris, white blood cells, platelets, anticoagulant, other liquid constituents and non-emulsified fat. The next phase involves the washing of the red blood cells by resuspension in saline. The final phase entails the removal of saline, consequently concentrating the red cells to a haematocrit of 0.6 [10].

Following autotransfusion, if the Hb or PCV became or remained below 10 g/dl or 30, respectively, homologous blood was transfused.

2.1. Statistical analysis
Fifty patients per arm (total 100) were selected because it enabled statistical power of 0.8, based on a 25% decrease in the volume of allogeneic blood transfused. Statistical analysis was performed using unpaired t- and {chi}2-tests, with significance taken as P<0.05.


    3. Results
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 References
 
There were no significant differences in gender (male:female group A 36 (64%):20 (36%), group C 41 (73%):15 (27%)) or age (mean±SEM group A 67.4±1.2 years, group C 65.3±1.4 years) between the two groups. The operations performed in each group are shown in Table 1.


View this table:
[in this window]
[in a new window]
 
Table 1. Distribution of operations performed

 
Cardiopulmonary bypass (CPB) and cross-clamp (XC) times were the same in both groups (group A 81±3.8 and 53±2.8 min, group C 77±3.5 and 47±2.8 min).

There was no significant difference in mean total mediastinal drainage (A: 652±51 ml, C: 686±50 ml) between groups (P=0.6310) (Fig. 1) .



View larger version (18K):
[in this window]
[in a new window]
 
Fig. 1. Total mediastinal drainage.

 
Forty six group C patients required banked blood. Ten patients in group C and 16 patients in group A did not receive any blood. Five group A patients met the criteria for autotransfusion, but as there was no mediastinal drainage these patients went directly to receive banked blood. Twelve group A patients were autotransfused and did not need a further transfusion. Twenty three group A patients, were autotransfused and did require subsequent banked blood transfusion (Table 2).


View this table:
[in this window]
[in a new window]
 
Table 2. Post-operative blood requirements

 
The number of patients therefore requiring banked blood transfusion in group A (28, 50%) was significantly less than those in group C (4, 82%) (P=0.0003). This remained the case when patients undergoing CABG alone were compared (group A 18/40 (45%), group C 29/37 (78%) (P=0.002).

The volume of banked blood transfused in the first 24 h following surgery was also significantly less in group A (298±49 ml) compared to group C (508±49 ml) (P=0.0028).

There was no significant difference in total blood requirement (i.e. volume autotransfused+volume of banked blood transfused) between each group; group A (403±50 ml) compared to group C (508±50 ml) (P=0.0028) (Fig. 2) .



View larger version (17K):
[in this window]
[in a new window]
 
Fig. 2. Total blood transfused per patient.

 
Day 1 postoperative haemoglobin concentrations were significantly higher in group A patients, mean 11.2±0.1 g/dl compared to group C mean 10.6±0.1 g/dl. The Hb concentration on days 1, 2 and 5 and length of hospital stay are shown in Table 3. The length of hospital stay in group A was 7.3±0.39 days, significantly less than in group C, 9.7±0.7 days (P=0.009).


View this table:
[in this window]
[in a new window]
 
Table 3. Day 1, 2 and 5 Hb concentration and length of hospital staya

 
Postoperative complications were similar in the two study groups. One patient in the control group and three patients in the autotransfusion group had re-operations for operative bleeding. There was one death in the control group due to a cerebrovascular accident and one death in the autotransfusion group due to renal failure.


    4. Discussion
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 References
 
These data demonstrate that selective postoperative autotransfusion significantly decreases the requirement for banked (allogeneic) blood, both in terms of the mean volume transfused and the number of patients requiring a transfusion. In addition, day 1 postoperative haemoglobin and packed cell volume levels are also higher in patients following autotransfusion.

There was no significant difference between the two study groups with respect to cardiopulmonary bypass (CPB) time or type of operation. These variables were initially believed to have an affect on transfusion requirements [11], however, Cosgrove et al. demonstrated that neither number of grafts nor duration of CPB correlated with transfusion requirements [12]. In the same way, a number of studies have suggested that postoperative chest tube drainage no longer differs after revascularization, valvular or combined surgical procedures [13].

Although the length of hospital stay for patients in the autotransfusion group was significantly less, it is unwise to draw immediate conclusions due to the number of confounding factors (concomitant disease, social situation, etc.) associated with this variable. Similarly, attempts by others to link banked transfusions with outcome such as length of stay or mortality in surgical patients have been unsuccessful [9].

Five of the subjects in group A required autotransfusion according to the protocol but did not receive any of their own packed red cells. This was because, according to the protocol they required blood on arrival in ITU, at which time there was no mediastinal drainage. It was also noted that some patients in group A returned from the operating theatre with a haemoglobin concentration which merited autotransfusion but with a relatively small volume of postoperative shed mediastinal fluid (less than 200 ml) in the collection reservoir. Washing of this fluid produced a low yield (<50 ml) and banked blood transfusions were required. However, 1–2 h postoperatively, there was enough in the reservoir to warrant autotransfusion. Modifications to the indications for transfusion would further decrease the number of patients receiving banked blood.

Prospective and controlled trials have disagreed over the efficacy of intra- and postoperative blood salvage in conserving blood in cardiac surgery patients. This disparity of results may be explained, in part, by differences in transfusion practices [9]. Different institutions function using varying combinations of the blood conservation techniques, many of which were not applied in the earlier prospective randomized studies [1416], hence it is difficult to compare results.

Morris et al. [17], allowed the Hb to fall to 7.5 g/dl before transfusing. Intraoperative autotransfusion was also administered to all patients in the autotransfusion group, and postoperative autotransfusion volumes were determined by the volume of mediastinal drainage. However, the conclusions that were drawn are in accordance with the findings in this study, i.e. addition of routine autotransfusion to a current practice of aggressive blood conservation further reduces the requirement for postoperative allogeneic banked blood transfusion in cardiac surgery patients [17].

In 1978, Schaff et al. studied postoperative autotransfusion in 114 patients undergoing cardiac surgery [15]. Only 52% of patients randomized to receive autotransfusion actually received autotransfused blood, however overall, a 50% reduction in the amount of banked blood received by this group was demonstrated. The criteria for receiving autotransfusion was more than 400 ml of blood lost in the initial 4 h following surgery, and the threshold for banked blood transfusion was a postoperative haematocrit of less than 0.35, a higher level than is generally accepted in today's practice [15,17].

One year later, Thurer et al. reported on a comparable study which also involved additional blood conserving techniques [16]. Reinfusion of shed mediastinal fluid was based on clinical evaluation of the patient and 83% of patients randomized into this group received autotransfused blood. However, on analysis of the results there was no significant reduction either in the amount of banked blood transfused or the number of patients requiring a transfusion, and it was concluded that there is no incremental benefit of reinfusion of shed mediastinal fluid when other attempts to conserve blood are used [16,17]. Page et al. made similar observations in patients with a low level of postoperative bleeding [18], but found that autotransfusion of patients with bleeding sufficient to yield more than 500 ml blood reduced the requirements for banked blood by nearly 50%, an observation similar to that of Schaff et al. [15,17,18].

More recently, Kochamba et al. combined an autotransfusion protocol with intra-operative haemodilution and found that this group of patients had 45% less homologous blood transfused and that 52% of the group required no blood products [19]. De Varennes et al. also demonstrated that reinfusion of shed mediastinal fluid reduces exposure to homologous blood transfusion. In addition, it was observed that autotransfusion reduces the number of re-exploration operations for coagulopathy-related postoperative haemorrhage [20].

Autotransfusion of washed mediastinal fluid is safe and the packed red cells it generates have definite advantages over allogeneic blood with respect to the risks of disease transmission or transfusion reaction.

Normovolaemic anaemia after cardiac surgery is well tolerated [12,2123]. An algorithm approach for use of autotransfusion that accounts for the volume of blood in the collection reservoir and haemoglobin level and clinical condition of the patient may further maximize benefits of autotransfusion.

This study was conducted to determine whether the use of postoperative autotransfusion reduced the requirement for banked blood transfusion following cardiac surgery. It was formulated as a single centre, randomized, controlled trial, each group containing 56 patients. The results showed that postoperative autotransfusion significantly decreased both the number of patients requiring allogeneic transfusion and the volume of banked blood transfused. We recommend that it is routinely offered to patients undergoing cardiac surgery.


    References
 Top
 Abstract
 1. Introduction
 2. Methods
 3. Results
 4. Discussion
 References
 

  1. National Blood Authority Annual Report, National Blood Service, 1996.
  2. Cunningham S. National Blood Service, 1997.
  3. Goodnough L., Soegiarso R., Geha A. Blood lost and blood transfused in coronary artery bypass graft operation as implications for blood transfusion and blood conservation strategies. Surg Gynecol Obstet 1993;177:345-351.[Medline]
  4. McClelland B. Handbook of transfusion medicine, 2nd edn. . London: HMSO, 1996.
  5. Schreiber G., Busch M., Kleinman S., Korelitz J. The risk of transfusion-transmitted viral infections. New Engl J Med 1996;334:1685-1690.[Abstract/Free Full Text]
  6. Barbara J., Flanagan P. Blood transfusion risk: protecting against the unknown. Br Med J 1998;316:717-718.[Free Full Text]
  7. Ricketts M. Is Creutzfeldt-Jacob disease transmitted by blood? Is the absence of evidence of risk evidence of absence of risk?. Can Med Assoc J 1997;157:1367-1370.[Medline]
  8. Murphy P., Connery C., Hicks G., Blumberg N. Homologous blood transfusion as a risk factor for postoperative infection after coronary artery bypass graft operations. J Thorac Cardiovasc Surg 1992;104:1092-1099.[Abstract]
  9. Goodnough L., Bodner M., Martin J. Blood transfusion and blood conservation: cost and utilization issues. Am J Med Qual 1994;9:172-183.
  10. Fresenius CATS Operation Manual.
  11. Hardy J., Tremblay N., Robitaille D., Blain R., Carrier M. The stratification of cardiac surgical procedures according to use of blood products: a retrospective analysis of1480 cases. Can J Anaesth 1991;38:511-517.
  12. Cosgrove D., Loop F., Lytle B., Gill C., Golding L., Taylor P., Forsythe S. Determinants of blood utilization during myocardial revascularization. Ann Thorac Surg 1985;40:380-384.[Abstract]
  13. Belisle S., Hardy J. Haemorrhage and the use of blood products after adult cardiac operations: myths and realities. Ann Thorac Surg 1996;62:1908-1917.[Abstract/Free Full Text]
  14. Adan A., Brutel R., Haas F., van Zalk A., de Nooj E. Autotransfusion of drained mediastinal blood after cardiac surgery: a reappraisal. Thorac Cardiovasc Surg 1988;36:10-14.[Medline]
  15. Schaff H., Hauer J., Bell W., Gardner T., Donahoo J., Gott V., Brawley R. Autotransfusion of shed mediastinal blood after cardiac surgery. J Thorac Cardiovasc Surg 1978;75:632-641.[Abstract]
  16. Thurer R., Lytle B., Cosgrove D., Loop F. Autotransfusion following cardiac operations: a randomized, prospective study. Ann Thorac Surg 1979;27:500-507.[Abstract]
  17. Morris J., Seng Tan Y. Autotransfusion: is there a benefit in a current practice of aggressive blood conservation. Ann Thorac Surg 1994;58:502-508.[Abstract]
  18. Page R., Russell G., Fox M., Fabri B., Lewis I., Williets T. Hard-shell cardiotomy reservoir for reinfusion of shed mediastinal blood. Ann Thorac Surg 1989;48:514-517.[Abstract]
  19. Kochamba G., Pfeffer T., Sintek C., Khonsari S. Intraoperative autotransfusion reduces blood loss after cardiopulmonary bypass. Ann Thorac Surg 1996;61:900-903.[Abstract/Free Full Text]
  20. de Varennes B., Nguyen D., Denis F., Ergina P., Latter D., Morin J. Reinfusion of mediastinal blood in CABG patients: impact on homologous transfusions and rate of re-exploration. J Card Surg 1996;11:387-395.[Medline]
  21. Goodnough L., Despotis G., Hogue C., Ferguson T. On the need for improved transfusion indicators in cardiac surgery. Ann Thorac Surg 1995;60:473-480.[Abstract/Free Full Text]
  22. Kirklin J., Lell W., Kouchoukos N. Hydroxyethyl starch versus albumin for colloid infusion following cardiopulmonary bypass in patients undergoing myocardial revascularisation. Ann Thorac Surg 1984;37:40.[Abstract]
  23. Tyson G., Sladen R., Spainhour V., Savitt M., Ferguson T., Wolfe W. Blood conservation in cardiac surgery. Ann Surg 1989;209:736-742.[Medline]



This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al.
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. Niranjan, G. Asimakopoulos, A. Karagounis, G. Cockerill, M. Thompson, and V. Chandrasekaran
Effects of cell saver autologous blood transfusion on blood loss and homologous blood transfusion requirements in patients undergoing cardiac surgery on- versus off-cardiopulmonary bypass: a randomised trial.
Eur. J. Cardiothorac. Surg., August 1, 2006; 30(2): 271 - 277.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
D Belway, F D Rubens, D Wozny, B Henley, and H J Nathan
Are we doing everything we can to conserve blood during bypass? A national survey
Perfusion, September 1, 2005; 20(5): 237 - 241.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G.J. Murphy, C.S. Rogers, W.B. Lansdowne, I. Channon, H. Alwair, A. Cohen, M. Caputo, and G.D. Angelini
Safety, efficacy, and cost of intraoperative cell salvage and autotransfusion after off-pump coronary artery bypass surgery: A randomized trial
J. Thorac. Cardiovasc. Surg., July 1, 2005; 130(1): 20 - 28.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
A. Shander, D. Moskowitz, and T. S. Rijhwani
The Safety and Efficacy of "Bloodless" Cardiac Surgery
Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2005; 9(1): 53 - 63.
[Abstract] [PDF]


Home page
PerfusionHome page
M A. Huybregts, R de Vroege, H M. Christiaans, A L Smith, and R C. Paulus
The use of a mini bypass system (Cobe Synergy) without venous and cardiotomy reservoir in a mitral valve repair: a case report
Perfusion, March 1, 2005; 20(2): 121 - 124.
[Abstract] [PDF]


Home page
PerfusionHome page
C R Daane, H D Golab, J H. Meeder, M J Wijers, and A J. Bogers
Processing and transfusion of residual cardiopulmonary bypass volume: effects on haemostasis, complement activation, postoperative blood loss and transfusion volume
Perfusion, March 1, 2003; 18(2): 115 - 121.
[Abstract] [PDF]


Home page
BMJHome page
N. McGill, D. O'Shaughnessy, R. Pickering, M. Herbertson, and R. Gill
Mechanical methods of reducing blood transfusion in cardiac surgery: randomised controlled trial
BMJ, June 1, 2002; 324(7349): 1299 - 1299.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Shibata, S. Takamoto, Y. Kotsuka, and H. Sato
Effectiveness of combined blood conservation measures in thoracic aortic operations with deep hypothermic circulatory arrest
Ann. Thorac. Surg., March 1, 2002; 73(3): 739 - 743.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
K. Kottke-Marchant and S. Sapatnekar
Hemostatic Abnormalities in Cardiopulmonary Bypass: Pathophysiologic and Transfusion Considerations
Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 187 - 206.
[Abstract] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Marcus P. Haw
James L. Monro
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dalrymple-Hay, M. J.R.
Right arrow Articles by Monro, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dalrymple-Hay, M. J.R.
Right arrow Articles by Monro, J. L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS